Cost-effectiveness of supplementary immunization for measles in India.

dc.contributor.authorDabral, Mayank
dc.date.accessioned2013-01-09T05:00:25Z
dc.date.available2013-01-09T05:00:25Z
dc.date.issued2009-11
dc.description.abstractObjective: This study aims to estimate the incremental cost effectiveness of a supplementary immunization activity (SIA) for measles in a district of India with measles vaccine coverage equivalent to the National average. Design: A state transition model is used to estimate the effect of routine vaccination with measles vaccine as well as with measles vaccine during the SIA. The model follows each sub-cohort in the target population at respective age (1-5 years) to five years of age, using age specific incidence rate and vaccination rate to determine the number of cases of measles. Using age specific incidence rates and complication rates for measles; deaths and disability adjusted life year (DALY) averted is estimated. Results: Using base-case assumptions, an estimated 65479 cases of measles and 1637 deaths due to measles will be prevented in a span of four years from a single supplementary immunization activity in a pediatric population (1-5 years of age) of size 839,473. The cost per measles vaccine dose delivered is INR 30. Using base case analysis the cost to avert a death is INR 15381 and the cost per disability adjusted life year (DALY) averted is INR 430. Conclusions: Supplementary immunization activity for measles is cost-effective. However, this cannot be considered superior to a second dose of measles in routine immunization.en_US
dc.identifier.citationDabral Mayank. Cost-effectiveness of supplementary immunization for measles in India. Indian Pediatrics. 2009 Nov; 46(11): 957-962.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/144214
dc.language.isoenen_US
dc.source.urihttps://indianpediatrics.net/nov2009/nov-957-962.htmen_US
dc.subjectCost-effectivenessen_US
dc.subjectIndiaen_US
dc.subjectMeaslesen_US
dc.subjectVaccineen_US
dc.subjectSupplementary immunizationen_US
dc.subject.meshChild, Preschool
dc.subject.meshCohort Studies
dc.subject.meshCost-Benefit Analysis
dc.subject.meshDecision Trees
dc.subject.meshHumans
dc.subject.meshImmunization, Secondary --economics
dc.subject.meshIndia
dc.subject.meshInfant
dc.subject.meshMeasles --economics
dc.subject.meshMeasles --prevention & control
dc.subject.meshMeasles Vaccine --economics
dc.titleCost-effectiveness of supplementary immunization for measles in India.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ip2009v46n11p957.pdf
Size:
87.89 KB
Format:
Adobe Portable Document Format
Description:
Journal article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: